Effect of Goal-Oriented GMFM-88 Based Program in Cerebral Palsy.
CP
1 other identifier
interventional
47
1 country
2
Brief Summary
Cerebral Palsy (CP) is a infancy and early childhood disorder that results in motor impairment caused by static and non-progressive lesions in the brain. It has an impact on both the neurological and musculoskeletal systems of the bod. According to the Cerebral Palsy Alliance Research Foundation (CPARF) \& WHO Cerebral Palsy Statistics 2023, approximately 17 million individuals experience some form of CP. This data underscores a notable prevalence rate of 1.5 cases per 1,000 live births within the High-Income Countries (HICs), limited but growing data are obtained from both the Lower Middle-Income Countries (LMICs. The incidence of CP among children in the Swabi district of Khyber Pakhtunkhwa, Pakistan, was 1.22 per 1000 live births. The overall prevalence in Pakistan is still not known, but according to recent documentation, it is estimated to be 4 out of every 1000 live births. The symptoms in CP encompassing atypical muscle contractions, alteration in posture and limitations in movement and physical activity. Furthermore,these symptoms are accompanied by disruptions in sensory perception and cognitive processing along with the challenges of communication, behavioral issues, epileptic seizures and secondary musculoskeletal complications. Motor deficit is present in 65.56% percent of CP cases as well as balance is impaired in most of the cases, and different impairments combinedly decreased overall quality of life (QOL). Because activities of daily living are decreased which in a result increases the caregiver's workload.Despite such a high prevalence of CP, there is still no standardized treatment approach implemented in the clinical settings due to their individualized needs and varying degrees of impairment. Consequently, our study seeks to address this gap by investigating the effect of Goal-Oriented individualized GMFM based programs on enhancing gross motor function, balance and quality of life. By elucidating the potential benefits of intervention, our study aims to contribute to the optimization of therapeutic approaches tailored to the different needs of children with CP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2024
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 15, 2024
CompletedFirst Submitted
Initial submission to the registry
November 18, 2024
CompletedFirst Posted
Study publicly available on registry
November 29, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedNovember 29, 2024
September 1, 2024
6 months
November 18, 2024
November 25, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Gross Motor Function
The GMFM-88 (Gross Motor Function Measure-88) is a scale used to assess gross motor function in children with CP.
At Baseline
Gross Motor Function
The GMFM-88 (Gross Motor Function Measure-88) is a scale used to assess gross motor function in children with CP.
Through study completion, at 16th week
Gross Motor Function
The GMFM-88 (Gross Motor Function Measure-88) is a scale used to assess gross motor function in children with CP.
followup of 2 weeks.
Balance
The Kids BESTest Scale (Balance Evaluation Systems Test) is used to assess balance in children with CP.
At Baseline
Balance
The Kids BESTest Scale (Balance Evaluation Systems Test) is used to assess balance in children with CP.
Through study completion, at 16th week
Balance
The Kids BESTest Scale (Balance Evaluation Systems Test) is used to assess balance in children with CP.
followup of 2 weeks.
Quality Of Life
The CP QOL (Cerebral Palsy Quality of Life) questionnaire is used to assess the quality of life in children with CP.
At Baseline
Quality Of Life
The CP QOL (Cerebral Palsy Quality of Life) questionnaire is used to assess the quality of life in children with CP.
Through study completion, at 16th week
Quality Of Life
The CP QOL (Cerebral Palsy Quality of Life) questionnaire is used to assess the quality of life in children with CP.
followup of 2 weeks.
Study Arms (1)
Intervention Group
EXPERIMENTALThe Intervention based on GMFM-88 items will be given 3 times per week for a duration of 40-45 minutes for each session for 16 weeks.
Interventions
Children will be assessed initially by using GMFM-88 and selecting specific items for individuals according to his/her needs with the help of experts and family. At least 3 items will be selected for each subject in which they score less such that 0, 1 or 2. Training based on those specific items will be given to the children. This is goal-oriented training in which, according to the needs of children training will be provided.
Eligibility Criteria
You may qualify if:
- Diagnosed Cerebral Palsy,
- Age 5-16 years,
- GMFCS Level I, II \& III,
- Able to understand instructions,
- With/ without any assistive devices.
You may not qualify if:
- CP children with any respiratory disorders,
- Undergoing surgery within the past 6 months,
- Botulinum injection within the last 6 months,
- Unstable seizures,
- Co-existing condition (ADHD, Metabolic Disorder, Progressive disorder),
- Any other co-morbid causing difficulty in performing tasks.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
ACELP Institute of Child Development
Karachi, Sindh, 07553, Pakistan
Dar-ul-Sukun
Karachi, Sindh, 74200, Pakistan
Related Publications (5)
Lee M, Ko Y, Shin MM, Lee W. The effects of progressive functional training on lower limb muscle architecture and motor function in children with spastic cerebral palsy. J Phys Ther Sci. 2015 May;27(5):1581-4. doi: 10.1589/jpts.27.1581. Epub 2015 May 26.
PMID: 26157267BACKGROUNDPaul S, Nahar A, Bhagawati M, Kunwar AJ. A Review on Recent Advances of Cerebral Palsy. Oxid Med Cell Longev. 2022 Jul 30;2022:2622310. doi: 10.1155/2022/2622310. eCollection 2022.
PMID: 35941906BACKGROUNDMcIntyre S, Goldsmith S, Webb A, Ehlinger V, Hollung SJ, McConnell K, Arnaud C, Smithers-Sheedy H, Oskoui M, Khandaker G, Himmelmann K; Global CP Prevalence Group*. Global prevalence of cerebral palsy: A systematic analysis. Dev Med Child Neurol. 2022 Dec;64(12):1494-1506. doi: 10.1111/dmcn.15346. Epub 2022 Aug 11.
PMID: 35952356BACKGROUNDCooper MS, Fahey MC, Mackay MT. Making waves: The changing tide of cerebral palsy. J Paediatr Child Health. 2022 Nov;58(11):1929-1934. doi: 10.1111/jpc.16186. Epub 2022 Sep 6.
PMID: 36066306BACKGROUNDAbd-Elfattah HM, Ameen FH, Elkalla RA, Aly SM, Abd-Elrahman NAF. Loaded Functional Strength Training versus Traditional Physical Therapy on Hip and Knee Extensors Strength and Function Walking Capacity in Children with Hemiplegic Cerebral Palsy: Randomized Comparative Study. Children (Basel). 2022 Jun 24;9(7):946. doi: 10.3390/children9070946.
PMID: 35883930BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Dr.Amna Aamir Khan, PhD
Ziauddin College of Physical Therapy, Ziauddin University
- PRINCIPAL INVESTIGATOR
Ifra Neelum, MPhil
Ziauddin College of Physical Therapy, Ziauddin University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
November 18, 2024
First Posted
November 29, 2024
Study Start
August 15, 2024
Primary Completion
February 1, 2025
Study Completion
March 1, 2025
Last Updated
November 29, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share